Back to HighTower Advisors, LLC HighTower Advisors, LLC

SRNESRNE
14 quarters

Position history for HighTower Advisors, LLCHighTower Advisors, LLC's holdings in Sorrento Therapeutics Inc

HighTower Advisors, LLC previously held 0 shares of SRNE (Sorrento Therapeutics Inc), worth $0 as of 2023-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$31,000

Total Shares Change

-8,977

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q1
Latest
Exited
0
-100.0%
$00.0%$0.37
0
2022-Q4
Decreased
35,512
-22.8%
$30,0000.0%$0.89
0
2022-Q3
Decreased
46,012
-4.2%
$72,0000.0%$1.58
0
2022-Q2
Increased
48,008
+33.3%
$96,0000.0%$1.99
28
2022-Q1
Increased
36,008
+22.0%
$84,0000.0%$2.37
26
2021-Q4
Decreased
29,518
-12.0%
$136,0000.0%$4.90
0
2021-Q3
Increased
33,543
+28.8%
$255,0000.0%$7.41
29
2021-Q2
Decreased
26,052
-26.1%
$252,0000.0%$9.70
0
2021-Q1
Increased
35,277
+26.8%
$291,0000.0%$8.00
29
2020-Q4
Increased
27,828
+182.4%
$191,0000.0%$7.24
37
2020-Q3
Decreased
9,853
-47.7%
$110,0000.0%$11.60
0
2020-Q2
Decreased
18,845
-18.0%
$120,0000.0%$6.11
0
2020-Q1
Increased
22,977
+155.9%
$43,0000.0%$1.85
33
2019-Q4
New
8,977
-
$31,0000.0%$3.34
27

Other major holders of SRNE: BNP PARIBAS FINANCIAL MARKETS, Steward Partners Investment Advisory, LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used